704 results on '"Belshe, Robert B."'
Search Results
2. Safety, Efficacy, and Effectiveness of Live, Attenuated, Cold-Adapted Influenza Vaccine in an Indicated Population Aged 5-49 Years
3. A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066)
4. Safety, Efficacy and Effectiveness of Cold-Adapted, Live, Attenuated, Trivalent, Intranasal Influenza Vaccine in Adults and Children
5. Mucosal Bacille Calmette-Guérin Vaccination of Humans Inhibits Delayed-Type Hypersensitivity to Purified Protein Derivative but Induces Mycobacteria-Specific Interferon-γ Responses
6. Development of a high-throughput β-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples
7. Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine
8. Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination
9. Featured Cover
10. Platelet response to influenza vaccination reflects effects of aging
11. Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects
12. Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009–2010 seasonal trivalent influenza vaccinations
13. Prolonged Proinflammatory Cytokine Production in Monocytes Modulated by Interleukin 10 After Influenza Vaccination in Older Adults
14. Phase II randomized, double-blinded comparison of a single high dose (5 × 108 TCID50) of modified vaccinia Ankara compared to a standard dose (1 × 108 TCID50) in healthy vaccinia-naïve individuals
15. Better Neutralization of Herpes Simplex Virus Type 1 (HSV-1) Than HSV-2 by Antibody From Recipients of GlaxoSmithKline HSV-2 Glycoprotein D2 Subunit Vaccine
16. Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women
17. Failure of Herpes Simplex Virus Glycoprotein D Antibodies to Elicit Antibody-Dependent Cell-Mediated Cytotoxicity: Implications for Future Vaccines
18. Epidemiology, Clinical Presentation, and Antibody Response to Primary Infection With Herpes Simplex Virus Type 1 and Type 2 in Young Women
19. Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations
20. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses
21. Platelet response to influenza vaccination reflects effects of aging
22. Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children
23. Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant
24. Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
25. Antibody Responses to Vaccinia Membrane Proteins after Smallpox Vaccination
26. The Immunogenetics of Smallpox Vaccination
27. Prevaccine Determination of the Expression of Costimulatory B7 Molecules in Activated Monocytes Predicts Influenza Vaccine Responses in Young and Older Adults
28. Neutralizing Antibody Kinetics and Immune Protection Against Herpes Simplex Virus 1 Genital Disease in Vaccinated Women
29. Interferon-γ-Mediated Antiviral Immunity against Orthopoxvirus Infection Is Provided by γδ T Cells [with Reply to Agrati et al]
30. Flow-Cytometric Detection of Vaccinia-Induced Memory Effector CD4⁺, CD8⁺, and γδTCR⁺ T Cells Capable of Antigen-Specific Expansion and Effector Functions
31. Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants
32. Neutralizing Antibody Kinetics and Immune Protection Against Herpes Simplex Virus 1 Genital Disease in Vaccinated Women.
33. Evaluation of Combined Live, Attenuated Respiratory Syncytial Virus and Parainfluenza 3 Virus Vaccines in Infants and Young Children
34. Induction of Human T Cell-Mediated Immune Responses after Primary and Secondary Smallpox Vaccination
35. Breakthrough Infections during Phase 1 and 2 Prime-Boost HIV-1 Vaccine Trials with Canarypox Vectors (ALVAC) and Booster Dose of Recombinant gp120 or gp160
36. Dose-Dependent Neutralizmg-Antibody Responses to Vaccinia
37. Phase 2 Evaluation of Parainfluenza Type 3 Cold Passage Mutant 45 Live Attenuated Vaccine in Healthy Children 6-18 Months Old
38. Stability of Undiluted and Diluted Vaccinia-Virus Vaccine, Dryvax
39. Canarypox Vaccines Induce Antigen-Specific Human γδ T Cells Capable of Interferon-γ Production
40. Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers
41. Evaluation of a Live, Cold-Passaged, Temperature-Sensitive, Respiratory Syncytial Virus Vaccine Candidate in Infancy
42. Correlates of Immune Protection Induced by Live, Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine
43. Comparison of the Safety, Vaccine Virus Shedding, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-Adapted, Administered to Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Adults
44. Male Genital Tuberculosis: A Review of the Literature with Instructive Case Reports
45. Induction of Immunologic Refractoriness in Adults by Meningococcal C Polysaccharide Vaccination
46. Safety and Immunogenicity of Low and High Doses of Trivalent Live Cold-Adapted Influenza Vaccine Administered Intranasally as Drops or Spray to Healthy Children
47. Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines
48. Supplement to: Efficacy results of a trial of a herpes simplex vaccine.
49. Evaluation of Live Attenuated Influenza Vaccines in Children 6-18 Months of Age: Safety, Immunogenicity, and Efficacy
50. Evaluation of a Recombinant Hemagglutinin Expressed in Insect Cells as an Influenza Vaccine in Young and Elderly Adults
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.